View in EDS

Olipudase alfa IgE-mediated anaphylaxis prevented by omalizumab and tailored desensitization in a child with acid sphingomyelinase deficiency.

Saved in:
Bibliographic Details
Title: Olipudase alfa IgE-mediated anaphylaxis prevented by omalizumab and tailored desensitization in a child with acid sphingomyelinase deficiency.
Authors: Fiori L; Metabolic Diseases Unit, Department of Pediatrics, Vittore Buzzi Children's Hospital, Milan, Italy., Tagi VM; Metabolic Diseases Unit, Department of Pediatrics, Vittore Buzzi Children's Hospital, Milan, Italy.; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy., Beretta S; Allergy Unit, Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy., Montanari C; Metabolic Diseases Unit, Department of Pediatrics, Vittore Buzzi Children's Hospital, Milan, Italy.; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy., Greco IP; Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy., Zuccotti G; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy., D'Auria E; Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.; Allergy Unit, Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy.
Source: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2026 May; Vol. 37 (5), pp. e70375.
Publication Type: Letter
Journal Info: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 9106718 Publication Model: Print Cited Medium: Internet ISSN: 1399-3038 (Electronic) Linking ISSN: 09056157 NLM ISO Abbreviation: Pediatr Allergy Immunol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1399-3038
DOI:10.1111/pai.70375